BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26702943)

  • 1. Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures.
    Waller JA; Chen F; Sánchez C
    Neuropharmacology; 2016 Apr; 103():143-54. PubMed ID: 26702943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vortioxetine promotes early changes in dendritic morphology compared to fluoxetine in rat hippocampus.
    Chen F; du Jardin KG; Waller JA; Sanchez C; Nyengaard JR; Wegener G
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):234-245. PubMed ID: 26711685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory.
    Bétry C; Etiévant A; Pehrson A; Sánchez C; Haddjeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():38-46. PubMed ID: 25524057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
    du Jardin KG; Müller HK; Sanchez C; Wegener G; Elfving B
    Eur J Pharmacol; 2016 Sep; 786():29-35. PubMed ID: 27235984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.
    Dale E; Zhang H; Leiser SC; Xiao Y; Lu D; Yang CR; Plath N; Sanchez C
    J Psychopharmacol; 2014 Oct; 28(10):891-902. PubMed ID: 25122043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.
    Sanchez C; Asin KE; Artigas F
    Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation.
    Jensen JB; du Jardin KG; Song D; Budac D; Smagin G; Sanchez C; Pehrson AL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):148-59. PubMed ID: 24284262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.
    du Jardin KG; Liebenberg N; Müller HK; Elfving B; Sanchez C; Wegener G
    Psychopharmacology (Berl); 2016 Jul; 233(14):2813-25. PubMed ID: 27236785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
    Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
    J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.
    Leiser SC; Pehrson AL; Robichaud PJ; Sanchez C
    Br J Pharmacol; 2014 Sep; 171(18):4255-72. PubMed ID: 24846338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats.
    Mørk A; Montezinho LP; Miller S; Trippodi-Murphy C; Plath N; Li Y; Gulinello M; Sanchez C
    Pharmacol Biochem Behav; 2013 Apr; 105():41-50. PubMed ID: 23380522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice.
    Guilloux JP; Mendez-David I; Pehrson A; Guiard BP; Repérant C; Orvoën S; Gardier AM; Hen R; Ebert B; Miller S; Sanchez C; David DJ
    Neuropharmacology; 2013 Oct; 73():147-59. PubMed ID: 23721744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.
    Bétry C; Pehrson AL; Etiévant A; Ebert B; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1115-27. PubMed ID: 23089374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain.
    El Mansari M; Lecours M; Blier P
    Psychopharmacology (Berl); 2015 Jul; 232(13):2343-52. PubMed ID: 25665528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
    Riga MS; Sánchez C; Celada P; Artigas F
    Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological properties of vortioxetine and its pre-clinical consequences].
    David DJ; Tritschler L; Guilloux JP; Gardier AM; Sanchez C; Gaillard R
    Encephale; 2016 Feb; 42(1 Suppl 1):1S12-23. PubMed ID: 26879252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of vortioxetine and duloxetine on resting-state functional connectivity in the awake rat.
    Pérez PD; Ma Z; Hamilton C; Sánchez C; Mørk A; Pehrson AL; Bundgaard C; Zhang N
    Neuropharmacology; 2018 Jan; 128():379-387. PubMed ID: 29104073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cognitive dysfunction in major depressive disorder--a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine.
    Pehrson AL; Leiser SC; Gulinello M; Dale E; Li Y; Waller JA; Sanchez C
    Eur J Pharmacol; 2015 Apr; 753():19-31. PubMed ID: 25107284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro effects of vortioxetine on molecules associated with neuroplasticity.
    Kugathasan P; Waller J; Westrich L; Abdourahman A; Tamm JA; Pehrson AL; Dale E; Gulinello M; Sanchez C; Li Y
    J Psychopharmacol; 2017 Mar; 31(3):365-376. PubMed ID: 27678087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse.
    Nackenoff AG; Simmler LD; Baganz NL; Pehrson AL; Sánchez C; Blakely RD
    ACS Chem Neurosci; 2017 May; 8(5):1092-1100. PubMed ID: 28272863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.